{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:30:35Z","timestamp":1782473435530,"version":"3.54.5"},"reference-count":59,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health, USA","award":["AG 079189"],"award-info":[{"award-number":["AG 079189"]}]},{"name":"National Institutes of Health, USA","award":["AG 077700"],"award-info":[{"award-number":["AG 077700"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Serotonin 5HT1A receptors may be affected in neurodegeneration, such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD). Using the selective 5HT1A receptor positron emission tomography (PET) imaging agent, [18F]mefway, autoradiographic studies from postmortem human brains of AD, PD, and cognitively normal (CN) subjects were carried out. Levels of [18F]mefway binding were compared with monoamine oxidase A (MAO-A) measured using [18F]FAZIN3 binding and dopamine D2\/D3 receptors measured using [18F]fallypride binding in the same subjects. Autoradiograms of brain sections of the anterior cingulate and corpus callosum from CN, PD, and AD subjects (n = 6 in each group) were analyzed. Significant increased binding of [18F]mefway was found in the AD (+30%) and PD (+11%) brains compared to CN brains. This increase positively correlated to increased [18F]FAZIN3 binding, suggesting greater 5HT1A receptor availability when MAO-A levels are higher. Differences in [18F]fallypride binding in the three groups were not significant. Our results support the finding that the availability of 5HT1A receptors in AD and PD is elevated in the anterior cingulate cortex and is negatively correlated with MAO-A. This upregulation may potentially be a response to lower serotonin levels due to the increased levels of MAO-A activity in this brain region or other neuroinflammatory changes. Thus, 5HT1A receptors may be a potential target for diagnostic and therapeutic approaches for AD and PD.<\/jats:p>","DOI":"10.3390\/biom15040592","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T06:12:06Z","timestamp":1744783926000},"page":"592","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["[18F]Mefway: Imaging Serotonin 5HT1A Receptors in Human Postmortem Alzheimer\u2019s and Parkinson\u2019s Disease Anterior Cingulate. Potential Applications to Human Positron Emission Tomography Studies"],"prefix":"10.3390","volume":"15","author":[{"given":"Noresa L.","family":"Gonzaga","sequence":"first","affiliation":[{"name":"Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, CA 92697, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3104-9523","authenticated-orcid":false,"given":"Fariha","family":"Karim","sequence":"additional","affiliation":[{"name":"Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, CA 92697, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9081-294X","authenticated-orcid":false,"given":"Christopher","family":"Liang","sequence":"additional","affiliation":[{"name":"Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, CA 92697, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-877X","authenticated-orcid":false,"given":"Jogeshwar","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, CA 92697, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ibneur.2022.09.007","article-title":"The neurodegenerative elderly syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease","volume":"13","author":"Caligiore","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41392-023-01427-2","article-title":"G protein-coupled receptors in neurodegenerative disease and psychiatric disorders","volume":"8","author":"Wong","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13041-024-01169-4","article-title":"Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitivie functions in Alzheimer\u2019s disease","volume":"17","author":"Azargoonjahromi","year":"2024","journal-title":"Mol. Brain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101556","DOI":"10.1016\/j.arr.2021.101556","article-title":"The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer\u2019s disease: A narrative review","volume":"75","author":"Aaldijk","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s12035-024-04333-y","article-title":"An expanded narrative review of neurotransmitter on Alzheimer\u2019s disease: The role of therapeutic interventions on neurotransmission","volume":"62","author":"Akyuz","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.22473","article-title":"Serotonin and Parkinson\u2019s disease: On movement, mood, and Madness","volume":"24","author":"Fox","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1212\/CPJ.0000000000200175","article-title":"Ulotaront, a trace amine-associated receptor 1\/serotonin 5HT1A agonist, in patients with Parkinsons disease psychosis","volume":"13","author":"Isaacson","year":"2023","journal-title":"Neurol. Clin. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109411","DOI":"10.1016\/j.neuropharm.2023.109411","article-title":"Serotonin 5HT1A receptors and their inteactions with adenosine A2A receptors in Parkinson\u2019s disease and dyskinesia","volume":"226","author":"Pinna","year":"2023","journal-title":"Neuropharmacology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107997","DOI":"10.1016\/j.neuropharm.2020.107997","article-title":"The selective HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets","volume":"167","author":"Fisher","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/cns.12306","article-title":"A postmortem study to compare agonist and antagonist 5HT1A receptor-binding sites in Alzheimer\u2019s disease","volume":"20","author":"Becker","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuropharm.2017.06.021","article-title":"Hippocampal 5HT1A receptor expression changes in prodromal stages of Alzheimers disease: Beneficial or deleterious","volume":"123","author":"Verdurand","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/09298673113209990215","article-title":"PET radiotracers for molecular imaging of serotonin 5HT1A receptors","volume":"21","author":"Billard","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1073\/pnas.0510237103","article-title":"Serotonin 1A receptors in the living brain of Alzheimer\u2019s disease patients","volume":"103","author":"Keep","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/01.wnl.0000271377.52421.4a","article-title":"Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment","volume":"69","author":"Truchot","year":"2007","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.neuroimage.2008.01.030","article-title":"A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer\u2019s disease","volume":"40","author":"Truchot","year":"2008","journal-title":"Neuroimage"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/01.WNL.0000031424.51127.2B","article-title":"Tremor in Parkinson\u2019s disease and serotonergic dysfunction: An 11C-WAY 100635 PET study","volume":"60","author":"Doder","year":"2003","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2008.07.001","article-title":"A role for the 5HT1A, 5HT4 and 5HT6 receptors in learning and memory","volume":"29","author":"King","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0079-6123(08)00912-6","article-title":"The dorsal raphe nucleus and serotonin: Implications for neuroplasticity linked to major depression and Alzheimer\u2019s disease","volume":"172","author":"Michelsen","year":"2008","journal-title":"Prog. Brain Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2008.06.011","article-title":"Molecular imaging of the 5HT1A receptor in relation to human cognition","volume":"195","author":"Borg","year":"2008","journal-title":"Behav. Brain Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2967\/jnumed.109.068908","article-title":"Serotonin receptor imaging: Clinically useful?","volume":"51","author":"Parsey","year":"2010","journal-title":"J. Nucl. Med."},{"key":"ref_21","first-page":"546","article-title":"Biomarkers for Alzheimers disease. Where we stand and where we are headed","volume":"79","author":"Mendez","year":"2019","journal-title":"Medicina"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sandhu, Y.K., Bath, H.S., Shergill, J., Liang, C., Syed, A.U., Ngo, A., Karim, F., Serrano, G.E., Beach, T.G., and Mukherjee, J. (2024). [18F]Flotaza for Ab plaque diagnostic imaging: Evaluation in postmortem human Alzheimer\u2019s disease brain hippocampus and PET\/CT imaging in 5xFAD transgenic mice. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147890"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13195-021-00838-z","article-title":"Aducanumab produced a clinically meaningful benefit in association with amyloid lowering","volume":"13","author":"Cummings","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/neurolint16020031","article-title":"[125I]IPC-Lecanemab: Synthesis and Evaluation of Ab plaque binding antibody and comparison with small molecule [18F]Flotaza and [125I]IBETA in postmortem human Alzheimer\u2019s disease","volume":"16","author":"Liang","year":"2024","journal-title":"Neurol. Int."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Syed, A.U., Liang, C., Patel, K.K., Mondal, R., Kamalia, V.M., Moran, T.R., Ahmed, S.T., and Mukherjee, J. (2023). Comparison of Monoamine oxidase-A, Ab plaques, Tau and Translocator protein in postmortem human Alzheimer\u2019s disease brain. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310808"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mukherjee, J., Ladwa, R.M., Liang, C., and Syed, A.U. (2022). Elevated monoamine oxidase-A in anterior cingulate of postmortem human Parkinson\u2019s disease: A potential surrogate biomarker for Lewy bodies?. Cells, 11.","DOI":"10.3390\/cells11244000"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cne.23919","article-title":"Comparative assessment of 18F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species-rodents, nonhuman primates and humans","volume":"524","author":"Mukherjee","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"ref_28","first-page":"203","article-title":"Serotonin 1A receptor density measured by F-18 mefway PT\/CT in mesolimbic cortex and raphe does not discriminate therapeutic response in patients with major depressive episode","volume":"64","author":"Barth","year":"2020","journal-title":"Ed. Minerva Medica"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Oh, S.J., Lyoo, C.H., Ryu, Y.H., and Choi, J.U. (2023). Assessing the applicability of PMOD residence times model for PET image-based radiation dosimetry. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-46822-5"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(96)01131-6","article-title":"Autoradiographic localization of 5HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635","volume":"745","author":"Hall","year":"1997","journal-title":"Brain Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/syn.10128","article-title":"Brain Imaging of 18F-fallypride in normal volunteers: Blood analysis, distribution, test-retest studies and preliminary assessment of sensitivity to aging effects on dopamine D-2\/D-3 receptors","volume":"46","author":"Mukherjee","year":"2002","journal-title":"Synapse"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e22183","DOI":"10.1002\/syn.22183","article-title":"Development and evaluation [125I]IPPI for tau imaging in post-mortem human Alzheimer\u2019s disease brain","volume":"74","author":"Mukherjee","year":"2021","journal-title":"Synapse"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/alz.13438","article-title":"Successful cognitive aging is associated with thicker anterior cingulate cortex and lower tau deposition compared to typical aging","volume":"20","author":"Pezzoli","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","article-title":"Earliest accumulation of b-amyloid occurs within the default-mode network and concurrently affects brain connectivity","volume":"8","author":"Palmqvist","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3233\/JAD-215558","article-title":"Visually identified Tau 18F-MK6240 PET patterns in symptomatic Alzheimer\u2019s disease","volume":"88","author":"Krishnadas","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1503\/jpn.210124","article-title":"The functional and structural associations of aberrant microglial activity in major depressive disorder","volume":"47","author":"Cakmak","year":"2022","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1176\/jnp.23.2.jnp121","article-title":"Anterior cingulate cortex: Unique role in cognition and emotion","volume":"23","author":"Stevens","year":"2011","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_38","first-page":"1697","article-title":"Synthesis and biological evaluation of a novel serotonin 5-HT1a receptor radioligand, N-{2-[4-(2-methoxyphenyl)piperazinyl]ethyl}-N-(2-pyridyl)-N-(4-18F-fluoromethylcyclohexane)carboxamide in rodents and imaging by PET in non-human primate","volume":"47","author":"Saigal","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0969-8051(94)00117-3","article-title":"Fluorinated benzamide neuroleptics 3. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3[F-18]-fluoropropyl)-2,3-dimethoxy-benzamide as an improved dopamine D-2 receptor tracer","volume":"22","author":"Mukherjee","year":"1995","journal-title":"Nucl. Med. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/neup.12189","article-title":"Arizona study of aging and neurodegenerative disorders and brain and body donation program","volume":"35","author":"Beach","year":"2015","journal-title":"Neuropathology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer\u2019s disease age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Mondal, R., Sandhu, Y.K., Kamalia, V.M., Delaney, B.A., Syed, A.U., Nguyen, G.A.H., Moran, T.R., Limpengco, R.R., Liang, C., and Mukherjee, J. (2023). Measurement of Ab amyloid and Tau in postmortem human Alzheimer\u2019s disease brain by immunohistochemistry analysis using QuPath and autoradiography using [18F]flotaza, [125I]IBETA and [124\/125I]IPPI. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041033"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2967\/jnumed.121.263254","article-title":"First-in-humans evaluation of 18F-SMBT-1, a novel 18F-labeled monoamine oxidase-B PET tracer for imaging reactive astrogliosis","volume":"63","author":"Villemagne","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"101957","DOI":"10.1016\/j.jchemneu.2021.101957","article-title":"The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders","volume":"114","author":"Jones","year":"2021","journal-title":"J. Chem. Neuroanat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11307-018-1165-3","article-title":"[11C]Harmine binding to brain monoamine oxidase A: Test-retest properties and noninvasive quantification","volume":"20","author":"Zanderigo","year":"2018","journal-title":"Mol. Imaging Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"103322","DOI":"10.1016\/j.nicl.2023.103322","article-title":"Moelcular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment","volume":"37","author":"Smith","year":"2023","journal-title":"Neuroimage Clin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/mds.28632","article-title":"Dopamine receptors in Parkinson\u2019s disease: A meta-analysis of imaging studies","volume":"36","author":"Kaasinen","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.nicl.2018.02.010","article-title":"[18F]Fallypride characterization of striatal and extrastriatal D2\/3 receptors in Parkinson\u2019s disease","volume":"18","author":"Stark","year":"2018","journal-title":"Neuroimage Clin."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/jcbfm.2013.55","article-title":"Establishing test-retest reliability of an adapted [18F]fallypride imaging protocol","volume":"33","author":"Dunn","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_50","first-page":"799","article-title":"Lower [18F]fallypride binding to dopamine D2\/D3 receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: A positron emission tomography study","volume":"50","author":"Ceccarini","year":"2019","journal-title":"Psychol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pscychresns.2006.12.012","article-title":"Dopamine D2\/D3 receptor binding in the anterior cingulate cortex and executive functioning","volume":"156","author":"Lumme","year":"2007","journal-title":"Psychiatry Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3758\/s13420-016-0243-0","article-title":"The roles of the anterior cingulate cortex and its dopamine receptors in self-paced cost-benefit decision making in rats","volume":"45","author":"Wang","year":"2017","journal-title":"Learn. Behav."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archpsyc.59.1.25","article-title":"Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia","volume":"59","author":"Suhara","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Martorana, A., and Koch, G. (2014). Is dopamine involved in Alzheimer\u2019s disease?. Front. Aging Neurosci., 6.","DOI":"10.3389\/fnagi.2014.00252"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Correia, A.S., and Vale, N. (2021). Antidepressants in Alzheimer\u2019s disease: A focus on the role of mirtazapine. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090930"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"114347","DOI":"10.1016\/j.ejmech.2022.114347","article-title":"Discovery of novel dual RAGE\/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer\u2019s disease and depression","volume":"236","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease","volume":"323","author":"Armstrong","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Suescun, J., Chandra, S., and Schiess, M.C. (2019). Chapter 13. The role of neuroinflammation in neurodegenerative disorders. Translational Inflammation, Academic Press.","DOI":"10.1016\/B978-0-12-813832-8.00013-3"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2967\/jnumed.119.229443","article-title":"Neuroinflammation PET imaging: Current opinion and future directions","volume":"61","author":"Jain","year":"2020","journal-title":"J. Nucl. Med."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/4\/592\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:15:33Z","timestamp":1760030133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/4\/592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["biom15040592"],"URL":"https:\/\/doi.org\/10.3390\/biom15040592","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}